| ASOS | 60.0 | 6 | 0 |
| Bosley – Hair Restoration & Transplant | 60.0 | 3 | 1 |
| Aveeno | 51.1 | 2 | 1 |
| Kérastase | 48.7 | 1 | 2 |
| hair styling product | 40.0 | 0 | 4 |
| Head & Shoulders | 38.6 | 1 | 1 |
| Bumble and bumble | 38.6 | 1 | 1 |
| Redken | 38.6 | 1 | 1 |
| TRESemmé | 38.6 | 1 | 1 |
| Living Proof | 38.6 | 1 | 1 |
| Live Bearded | 38.6 | 1 | 1 |
| Men's Health | 33.9 | 2 | 0 |
| Target Corporation | 33.9 | 2 | 0 |
| Lush | 33.9 | 2 | 0 |
| Nu Skin Enterprises | 33.9 | 2 | 0 |
| Neutrogena | 33.9 | 2 | 0 |
| Wallpaper | 33.9 | 2 | 0 |
| Miss Selfridge | 33.9 | 2 | 0 |
| GQ | 33.9 | 2 | 0 |
| Shea Moisture | 33.9 | 2 | 0 |
| Lab Series | 33.9 | 2 | 0 |
| hair conditioner | 27.3 | 0 | 2 |
| hair spray | 27.3 | 0 | 2 |
| Brylcreem | 27.3 | 0 | 2 |
| Pomade acne | 27.3 | 0 | 2 |
| hair clay | 27.3 | 0 | 2 |
| AG Hair Care | 27.3 | 0 | 2 |
| North American virginian witch hazel (hamamelis virginiana): based scalp care and protection for sensitive scalp, red scalp, and scalp burn-out | 27.3 | 0 | 2 |
| Hair loss: is there a relationship with hair care practices in Nigeria? | 27.3 | 0 | 2 |
| Efficacy of Cistanche Tubulosa and Laminaria Japonica Extracts (MK-R7) Supplement in Preventing Patterned Hair Loss and Promoting Scalp Health | 27.3 | 0 | 2 |
| Acetylenic polymers for hair styling products | 27.3 | 0 | 2 |
| hair care product | 27.3 | 0 | 2 |
| The analysis of scalp irritation by coacervates produced in hair shampoo via FTIR with focal plane array detector, X-ray photoelectron microscopy and HaCaT cells | 27.3 | 0 | 2 |
| Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult | 27.3 | 0 | 2 |
| Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia | 27.3 | 0 | 2 |
| Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia | 27.3 | 0 | 2 |
| Tinea capitis in two young women: possible favouring role of hair styling products | 27.3 | 0 | 2 |
| A Timosaponin B-II containing scalp care solution for improvement of scalp hydration, dandruff reduction and hair loss prevention: A comparative study on healthy volunteers before and after application | 27.3 | 0 | 2 |
| LB938 Use of a scalp clarifying shampoo in the treatment of lichen planopilaris and female pattern hair loss | 27.3 | 0 | 2 |
| A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss | 27.3 | 0 | 2 |
| A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss | 27.3 | 0 | 2 |
| hair styling tool accessory | 27.3 | 0 | 2 |
| hair curler clips & pin | 27.3 | 0 | 2 |
| hair dryer accessory | 27.3 | 0 | 2 |
| hair iron accessory | 27.3 | 0 | 2 |
| hair styling tool | 27.3 | 0 | 2 |
| combs & brush | 27.3 | 0 | 2 |
| hair styling tool set | 27.3 | 0 | 2 |
| hair loss concealer | 27.3 | 0 | 2 |
| hair loss treatment | 27.3 | 0 | 2 |
| Bumpits | 27.3 | 0 | 2 |
| DS Laboratories | 27.3 | 0 | 2 |
| Hair Genetics | 27.3 | 0 | 2 |
| Postnatal Hair Handbook | 27.3 | 0 | 2 |
| Lee Moon Won Korean Medicine Clinic | 27.3 | 0 | 2 |
| AWARE Hair | 27.3 | 0 | 2 |
| Nutrire | 27.3 | 0 | 2 |
| Mon Platin Professional | 27.3 | 0 | 2 |
| JUVA Haircare | 27.3 | 0 | 2 |
| Ceremonia | 27.3 | 0 | 2 |
| L'ange Hair, Inc. | 27.3 | 0 | 2 |
| L'ange | 27.3 | 0 | 2 |
| The Jerusalem Post | 21.4 | 1 | 0 |
| Urban Decay | 21.4 | 1 | 0 |
| GQ | 21.4 | 1 | 0 |
| La Roche-Posay | 21.4 | 1 | 0 |
| Q483551 | 21.4 | 1 | 0 |
| Baxter International | 21.4 | 1 | 0 |
| Dove | 21.4 | 1 | 0 |
| Dateline NBC | 21.4 | 1 | 0 |
| The Daily Beast | 21.4 | 1 | 0 |
| Meet the Press | 21.4 | 1 | 0 |
| Walgreens | 21.4 | 1 | 0 |
| John Paul Mitchell Systems | 21.4 | 1 | 0 |
| Kirkland & Ellis | 21.4 | 1 | 0 |
| CVS Pharmacy | 21.4 | 1 | 0 |
| Old Spice | 21.4 | 1 | 0 |
| Sephora | 21.4 | 1 | 0 |
| NBC News | 21.4 | 1 | 0 |
| Kiehl's | 21.4 | 1 | 0 |
| Q3342042 | 21.4 | 1 | 0 |
| The Jerusalem Report | 21.4 | 1 | 0 |
| The Art of Shaving | 21.4 | 1 | 0 |
| Aesop | 21.4 | 1 | 0 |
| Aussie | 21.4 | 1 | 0 |
| Aveda | 21.4 | 1 | 0 |
| Boots Opticians | 21.4 | 1 | 0 |
| C. O. Bigelow | 21.4 | 1 | 0 |
| Cetaphil | 21.4 | 1 | 0 |
| Dollar Shave Club | 21.4 | 1 | 0 |
| Hoda Kotb | 21.4 | 1 | 0 |
| Hooked: Muscle Women | 21.4 | 1 | 0 |
| Boots | 21.4 | 1 | 0 |
| British Vogue | 21.4 | 1 | 0 |
| L'Oréal Professionnel | 21.4 | 1 | 0 |
| Men's Journal | 21.4 | 1 | 0 |
| Suave | 21.4 | 1 | 0 |
| Tom's of Maine | 21.4 | 1 | 0 |
| Tree Hut | 21.4 | 1 | 0 |
| Ulta Beauty | 21.4 | 1 | 0 |
| MALIN+GOETZ | 21.4 | 1 | 0 |
| list of Walmart brands | 21.4 | 1 | 0 |
| Feel Good Food | 21.4 | 1 | 0 |
| Who, What, Wear | 21.4 | 1 | 0 |
| Feel Good You | 21.4 | 1 | 0 |
| Beauty Brands | 21.4 | 1 | 0 |
| Woman & Home | 21.4 | 1 | 0 |
| No7 product line | 21.4 | 1 | 0 |
| The Honest Company | 21.4 | 1 | 0 |
| Dermstore | 21.4 | 1 | 0 |
| Harry's | 21.4 | 1 | 0 |
| Moroccanoil Inc. | 21.4 | 1 | 0 |
| CeraVe | 21.4 | 1 | 0 |
| NBC Out | 21.4 | 1 | 0 |
| Dude Wipes | 21.4 | 1 | 0 |
| Baxter (France) | 21.4 | 1 | 0 |
| Baxter (South Korea) | 21.4 | 1 | 0 |
| hair dryer | 17.2 | 0 | 1 |
| Eritai | 17.2 | 0 | 1 |
| Iau | 17.2 | 0 | 1 |
| shampoo | 17.2 | 0 | 1 |
| bald head | 17.2 | 0 | 1 |
| hairstyle | 17.2 | 0 | 1 |
| afro | 17.2 | 0 | 1 |
| minoxidil | 17.2 | 0 | 1 |
| Sunsilk | 17.2 | 0 | 1 |
| Q747793 | 17.2 | 0 | 1 |
| trichomes | 17.2 | 0 | 1 |
| Naxos disease | 17.2 | 0 | 1 |
| sebaceous adenitis | 17.2 | 0 | 1 |
| Pantene | 17.2 | 0 | 1 |
| hair iron | 17.2 | 0 | 1 |
| hair wax | 17.2 | 0 | 1 |
| hair straightening | 17.2 | 0 | 1 |
| Trisquel | 17.2 | 0 | 1 |
| hairbrush | 17.2 | 0 | 1 |
| hair gel | 17.2 | 0 | 1 |
| plain language | 17.2 | 0 | 1 |
| hair loss medication | 17.2 | 0 | 1 |
| androgenic alopecia | 17.2 | 0 | 1 |
| frontal fibrosing alopecia | 17.2 | 0 | 1 |
| alopecia X | 17.2 | 0 | 1 |
| alopecia | 17.2 | 0 | 1 |
| Los Muchachos de antes no usaban gomina | 17.2 | 0 | 1 |
| GDevelop | 17.2 | 0 | 1 |
| follicular unit transplantation | 17.2 | 0 | 1 |
| Brazilian hair straightening | 17.2 | 0 | 1 |
| Selsun Blue | 17.2 | 0 | 1 |
| effective results in number theory | 17.2 | 0 | 1 |
| Schobrunn | 17.2 | 0 | 1 |
| Aqua Velva | 17.2 | 0 | 1 |
| hair care | 17.2 | 0 | 1 |
| Clairol | 17.2 | 0 | 1 |
| Clear | 17.2 | 0 | 1 |
| Elvive | 17.2 | 0 | 1 |
| Herbal Essences | 17.2 | 0 | 1 |
| Proraso | 17.2 | 0 | 1 |
| 5-alpha-reductase inhibitors | 17.2 | 0 | 1 |
| Alopecia in animals | 17.2 | 0 | 1 |
| management of baldness | 17.2 | 0 | 1 |
| Avlon Industries | 17.2 | 0 | 1 |
| backcombing | 17.2 | 0 | 1 |
| cicatricial alopecia | 17.2 | 0 | 1 |
| Dread perming | 17.2 | 0 | 1 |
| Good Hair Day | 17.2 | 0 | 1 |
| Goody Products, Inc. | 17.2 | 0 | 1 |
| hair restoration | 17.2 | 0 | 1 |
| Hair serum | 17.2 | 0 | 1 |
| hairstyling tool | 17.2 | 0 | 1 |
| hairstyling product | 17.2 | 0 | 1 |
| satin glass | 17.2 | 0 | 1 |
| Kirikiri | 17.2 | 0 | 1 |
| Plain Language Movement | 17.2 | 0 | 1 |
| Marjorie Joyner | 17.2 | 0 | 1 |
| noncicatricial alopecia | 17.2 | 0 | 1 |
| Parachute | 17.2 | 0 | 1 |
| Psssssst | 17.2 | 0 | 1 |
| Rusk | 17.2 | 0 | 1 |
| S-Curl | 17.2 | 0 | 1 |
| Salon Selectives | 17.2 | 0 | 1 |
| Scalp Treatment | 17.2 | 0 | 1 |
| Category:Animal hair products | 17.2 | 0 | 1 |
| The Heathen Chinee | 17.2 | 0 | 1 |
| traction alopecia | 17.2 | 0 | 1 |
| Twink | 17.2 | 0 | 1 |
| Yesterday's Boys Didn't Use Hair Fixers | 17.2 | 0 | 1 |
| hereditary hair loss | 17.2 | 0 | 1 |
| postpartum alopecia | 17.2 | 0 | 1 |
| hair loss in children | 17.2 | 0 | 1 |
| Category:Hair care equipment | 17.2 | 0 | 1 |
| Category:Hair care | 17.2 | 0 | 1 |
| Category:Hair care products | 17.2 | 0 | 1 |
| hair care device | 17.2 | 0 | 1 |
| Sanguozhi Pinghua | 17.2 | 0 | 1 |
| MA CHÉRIE | 17.2 | 0 | 1 |
| EMERON | 17.2 | 0 | 1 |
| dry shampoo | 17.2 | 0 | 1 |
| hair oil | 17.2 | 0 | 1 |
| Q11688065 | 17.2 | 0 | 1 |
| Q11903331 | 17.2 | 0 | 1 |
| hairdressing | 17.2 | 0 | 1 |
| Hesperis bottae | 17.2 | 0 | 1 |
| Head Shampoo | 17.2 | 0 | 1 |
| hair cloning | 17.2 | 0 | 1 |
| Hesperis straussii | 17.2 | 0 | 1 |
| bear's grease | 17.2 | 0 | 1 |
| King Creosote Says "Buy The Bazouki Hair Oil" | 17.2 | 0 | 1 |
| hl | 17.2 | 0 | 1 |
| A brief summary, in plain language, of the most important laws concerning women, together with a few observations thereon | 17.2 | 0 | 1 |
| anti alopecic | 17.2 | 0 | 1 |
| temporary loss of hair | 17.2 | 0 | 1 |
| The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation | 17.2 | 0 | 1 |
| Sandra Fisher-Martins | 17.2 | 0 | 1 |
| Apache NiFi | 17.2 | 0 | 1 |
| InStyler | 17.2 | 0 | 1 |
| Interventions for female pattern hair loss | 17.2 | 0 | 1 |
| Towards dissecting the pathogenesis of retinoid-induced hair loss: all-trans retinoic acid induces premature hair follicle regression (catagen) by upregulation of transforming growth factor-beta2 in the dermal papilla | 17.2 | 0 | 1 |
| The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor | 17.2 | 0 | 1 |
| Female pattern alopecia: current perspectives | 17.2 | 0 | 1 |
| Premature grey hair and hair loss among smokers: a new opportunity for health education? | 17.2 | 0 | 1 |
| Evidence-based patient choice: a prostate cancer decision aid in plain language | 17.2 | 0 | 1 |
| Tangle Teezer | 17.2 | 0 | 1 |
| Plain language radio checks | 17.2 | 0 | 1 |
| Crewstation analysis programs - an easy to use personal computer-based lighting and visibility analysis software package for underground mining equipment | 17.2 | 0 | 1 |
| Health hazard evaluation report: HETA-89-138-2215, Chapple Hair Styling Salon, Garfield Heights, Ohio | 17.2 | 0 | 1 |
| Plain language about shiftwork | 17.2 | 0 | 1 |
| El trabajo por turnos en lenguaje sencillo | 17.2 | 0 | 1 |
| Interventions for female pattern hair loss | 17.2 | 0 | 1 |
| Hair loss and regeneration performed on animal models | 17.2 | 0 | 1 |
| Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview | 17.2 | 0 | 1 |
| Classifications of patterned hair loss: a review | 17.2 | 0 | 1 |
| Nutrition of women with hair loss problem during the period of menopause | 17.2 | 0 | 1 |
| Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss | 17.2 | 0 | 1 |
| Female Pattern Hair Loss: a clinical and pathophysiological review | 17.2 | 0 | 1 |
| Patchy hair loss in an otherwise healthy man | 17.2 | 0 | 1 |
| Female pattern hair loss | 17.2 | 0 | 1 |
| Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata | 17.2 | 0 | 1 |
| A review of hair product use on breast cancer risk in African American women | 17.2 | 0 | 1 |
| Towards a molecular understanding of hair loss and its treatment | 17.2 | 0 | 1 |
| Hair loss as a sign of Kawasaki disease | 17.2 | 0 | 1 |
| Female pattern hair loss | 17.2 | 0 | 1 |
| Diagnosing and treating hair loss | 17.2 | 0 | 1 |
| Allergic contact dermatitis to cocamidopropylbetaine in hair shampoo | 17.2 | 0 | 1 |
| Pattern hair loss in men: diagnosis and medical treatment | 17.2 | 0 | 1 |
| Trichoscopy: a new method for diagnosing hair loss | 17.2 | 0 | 1 |
| Medical treatments for male and female pattern hair loss | 17.2 | 0 | 1 |
| Lithium and hair loss in childhood | 17.2 | 0 | 1 |
| Direct-to-consumer advertising. Finasteride for male pattern hair loss | 17.2 | 0 | 1 |
| Beneficial Effects of Astragaloside IV for Hair Loss via Inhibition of Fas/Fas L-Mediated Apoptotic Signaling | 17.2 | 0 | 1 |
| shampoo and set | 17.2 | 0 | 1 |
| Development of autoimmune hair loss disease alopecia areata is associated with cardiac dysfunction in C3H/HeJ mice | 17.2 | 0 | 1 |
| p53-dependent transcriptional regulation of EDA2R and its involvement in chemotherapy-induced hair loss | 17.2 | 0 | 1 |
| Progressive hair loss and myocardial degeneration in rough coat mice: reduced lysyl oxidase-like (LOXL) in the skin and heart | 17.2 | 0 | 1 |
| Bipedality and hair loss in human evolution revisited: The impact of altitude and activity scheduling | 17.2 | 0 | 1 |
| Characterization of hairless (Hr) and FGF5genes provides insights into the molecular basis of hair loss in cetaceans | 17.2 | 0 | 1 |
| Avoidance of overheating and selection for both hair loss and bipedality in hominins | 17.2 | 0 | 1 |
| Part 2 of a 4-part series Hair Products: Trends and Alternatives: Data from the American Contact Alternatives Group | 17.2 | 0 | 1 |
| Healthy hair starts with a healthy body: hair stylists as lay health advisors to prevent chronic kidney disease | 17.2 | 0 | 1 |
| Use of silicon for skin and hair care: an approach of chemical forms available and efficacy | 17.2 | 0 | 1 |
| sway | 17.2 | 0 | 1 |
| Sanguisorba Officinalis Root Extract Has FGF-5 Inhibitory Activity and Reduces Hair Loss by Causing Prolongation of the Anagen Period | 17.2 | 0 | 1 |
| A review of surgical methods (excluding hair transplantation) and their role in hair loss management today | 17.2 | 0 | 1 |
| Easy to use plastic optical fiber-based biosensor for detection of butanal | 17.2 | 0 | 1 |
| Brazilian keratin hair treatment: a review | 17.2 | 0 | 1 |
| Hair loss and defective T- and B-cell function in mice lacking ORAI1 | 17.2 | 0 | 1 |
| Prediction models and development of an easy to use open-access tool for measuring lung function of individuals with motor complete spinal cord injury | 17.2 | 0 | 1 |
| RatLab: an easy to use tool for place code simulations | 17.2 | 0 | 1 |
| By the way, doctor, I'm thinking of trying a laser to remove the fine hair above my upper lip. How do lasers measure up to electrolysis, waxing, and other methods of removing hair? | 17.2 | 0 | 1 |
| Temporary hair loss using the long-pulsed alexandrite laser at 20 milliseconds | 17.2 | 0 | 1 |
| Fractional Photothermolysis Laser Treatment of Male Pattern Hair Loss | 17.2 | 0 | 1 |
| Exposure data for cosmetic products: facial cleanser, hair conditioner, and eye shadow | 17.2 | 0 | 1 |
| Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients | 17.2 | 0 | 1 |
| 'Tweaked' GammaPlan for target volume measurement in non-fiducial based images: a simple routine for follow-up assessment | 17.2 | 0 | 1 |
| Psoriatic alopecia: acute and chronic hair loss in 47 patients with scalp psoriasis | 17.2 | 0 | 1 |
| Synergistic effects of high molecular weight polyethylene oxide (PEO) and cationic cellulosic polymers on conditioning properties of hair care products [corrected]. | 17.2 | 0 | 1 |
| The current role of laser/light sources in the treatment of male and female pattern hair loss | 17.2 | 0 | 1 |
| Associations among hair loss, oral sulfur-containing gases, and gastrointestinal and metabolic linked diseases in Japanese elderly men: pilot study | 17.2 | 0 | 1 |
| Ultra-high-performance liquid chromatography–tandem mass spectrometry measurement of climbazole deposition from hair care products onto artificial skin and human scalp | 17.2 | 0 | 1 |
| Hair loss in children | 17.2 | 0 | 1 |
| Hormonal therapy in female pattern hair loss | 17.2 | 0 | 1 |
| Finasteride in the treatment of men with frontal male pattern hair loss | 17.2 | 0 | 1 |
| Diffuse hair loss. | 17.2 | 0 | 1 |
| Therapeutic Efficacy of a Combination Therapy of Topical 17α-Estradiol and Topical Minoxidil on Female Pattern Hair Loss: A Noncomparative, Retrospective Evaluation | 17.2 | 0 | 1 |
| Conditional activin receptor type 1B (Acvr1b) knockout mice reveal hair loss abnormality. | 17.2 | 0 | 1 |
| Controversy: Is there a role for adjuvants in the management of male pattern hair loss? | 17.2 | 0 | 1 |
| Treatment of hair loss | 17.2 | 0 | 1 |
| Update on the pathogenesis, genetics and medical treatment of patterned hair loss. | 17.2 | 0 | 1 |
| Comparing the Effects of Zinc Sulfate, Calcium Pantothenate, Their Combination and Minoxidil Solution Regimens on Controlling Hair Loss in Women: A Randomized Controlled Trial | 17.2 | 0 | 1 |
| Molecular basis for hair loss in mice carrying a novel nonsense mutation (Hrrh-R ) in the hairless gene (Hr). | 17.2 | 0 | 1 |
| Hair loss in psychopharmacology | 17.2 | 0 | 1 |
| Childhood hair product use and earlier age at menarche in a racially diverse study population: a pilot study | 17.2 | 0 | 1 |
| The effect of a 1550 nm fractional erbium–glass laser in female pattern hair loss | 17.2 | 0 | 1 |
| Practical management of hair loss. | 17.2 | 0 | 1 |
| Low iron stores: a risk factor for excessive hair loss in non-menopausal women | 17.2 | 0 | 1 |
| Effect of oral intake of choline-stabilized orthosilicic acid on hair tensile strength and morphology in women with fine hair | 17.2 | 0 | 1 |
| Chemical aspects of hair loss and its cosmetological significance | 17.2 | 0 | 1 |
| Medical management of male pattern hair loss | 17.2 | 0 | 1 |
| Hair loss and hypothalamic-pituitary-adrenocortical axis activity in captive rhesus macaques (Macaca mulatta) | 17.2 | 0 | 1 |
| Association Between Human Hair Loss and the Expression Levels of Nucleolin, Nucleophosmin, and UBTF Genes | 17.2 | 0 | 1 |
| Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group | 17.2 | 0 | 1 |
| The biology of hair care | 17.2 | 0 | 1 |
| Clinical effectiveness and tolerance of climbazole containing dandruff shampoo in patients with seborrheic scalp eczema | 17.2 | 0 | 1 |
| Male pattern hair loss: prevention rather than regrowth | 17.2 | 0 | 1 |
| Female pattern hair loss in complete androgen insensitivity syndrome | 17.2 | 0 | 1 |
| A novel cosmetic approach to treat thinning hair | 17.2 | 0 | 1 |
| Recurrent hair loss resulting from generalized proximal trichorrhexis nodosa in a nigerian female | 17.2 | 0 | 1 |
| Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: a pilot study | 17.2 | 0 | 1 |
| Nutritional factors and hair loss | 17.2 | 0 | 1 |
| Beyond goosebumps: does the arrector pili muscle have a role in hair loss? | 17.2 | 0 | 1 |
| The shampoo pH can affect the hair: Myth or Reality? | 17.2 | 0 | 1 |
| Hair loss | 17.2 | 0 | 1 |
| Persistent sexual side effects of finasteride for male pattern hair loss. | 17.2 | 0 | 1 |
| Treatment of female pattern hair loss with the androgen receptor antagonist flutamide | 17.2 | 0 | 1 |
| Hair on a gene string: recent advances in understanding the molecular genetics of hair loss | 17.2 | 0 | 1 |
| Shedding: how to manage a common cause of hair loss. | 17.2 | 0 | 1 |
| Production rates of testosterone and of dihydrotestosterone in female pattern hair loss | 17.2 | 0 | 1 |
| Common hair loss disorders | 17.2 | 0 | 1 |
| Hair loss: diagnosis and management | 17.2 | 0 | 1 |
| Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness | 17.2 | 0 | 1 |
| African american women, hair care, and health barriers | 17.2 | 0 | 1 |
| Pteros: fast and easy to use open-source C++ library for molecular analysis. | 17.2 | 0 | 1 |
| MDs' failure to use plain language can lead to the courtroom | 17.2 | 0 | 1 |
| What is wrong with the 30-year-old practice of scalp cooling for the prevention of chemotherapy-induced hair loss? | 17.2 | 0 | 1 |
| Genetic hair loss | 17.2 | 0 | 1 |
| The psychology of hair loss and its implications for patient care | 17.2 | 0 | 1 |
| Hair care and hair care products | 17.2 | 0 | 1 |
| A questionnaire survey about hair loss after chemotherapy for breast cancer | 17.2 | 0 | 1 |
| How to Diagnose Hair Loss | 17.2 | 0 | 1 |
| Management of male pattern hair loss. | 17.2 | 0 | 1 |
| Videodermatoscopy enhances diagnostic capability in some forms of hair loss | 17.2 | 0 | 1 |
| Female pattern hair loss. | 17.2 | 0 | 1 |
| Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss | 17.2 | 0 | 1 |
| Radiation-induced temporary hair loss as a radiation damage only occurring in patients who had the combination of MDCT and DSA. | 17.2 | 0 | 1 |
| Hair care products: waving, straightening, conditioning, and coloring | 17.2 | 0 | 1 |
| The use of low-level light therapy in the treatment of androgenetic alopecia and female pattern hair loss | 17.2 | 0 | 1 |
| Low-level laser (light) therapy (LLLT) for treatment of hair loss | 17.2 | 0 | 1 |
| Nonsurgical Therapy for Hair Loss | 17.2 | 0 | 1 |
| Prevention of chemotherapy-induced hair loss by scalp cooling | 17.2 | 0 | 1 |
| Adult-onset hair loss in Chesapeake Bay retrievers: a clinical and histological study | 17.2 | 0 | 1 |
| Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study | 17.2 | 0 | 1 |
| Excess granulation tissue and hair loss following acitretin | 17.2 | 0 | 1 |
| Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review. | 17.2 | 0 | 1 |
| Hair Loss in Women | 17.2 | 0 | 1 |
| Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring? | 17.2 | 0 | 1 |
| Premature sexual development in children following the use of estrogen- or placenta-containing hair products | 17.2 | 0 | 1 |
| Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia | 17.2 | 0 | 1 |
| Residential treatment for posttraumatic stress disorder in the Department of Veterans Affairs: A national perspective on perceived effective ingredients | 17.2 | 0 | 1 |
| Hair loss in women with hyperandrogenism: four cases responding to finasteride | 17.2 | 0 | 1 |
| Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss | 17.2 | 0 | 1 |
| Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women | 17.2 | 0 | 1 |
| Finasteride treatment of female pattern hair loss | 17.2 | 0 | 1 |
| The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride | 17.2 | 0 | 1 |
| Hair loss and hirsutism in the elderly | 17.2 | 0 | 1 |
| Hair loss: an overview. | 17.2 | 0 | 1 |
| Female pattern hair loss may be triggered by low oestrogen to androgen ratio. | 17.2 | 0 | 1 |
| Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss | 17.2 | 0 | 1 |
| Which plant for which skin disease? Part 2: Dermatophytes, chronic venous insufficiency, photoprotection, actinic keratoses, vitiligo, hair loss, cosmetic indications | 17.2 | 0 | 1 |
| 5α-reductase inhibition and hair growth promotion of some Thai plants traditionally used for hair treatment | 17.2 | 0 | 1 |
| Hair loss in cancer chemotherapeutic patients | 17.2 | 0 | 1 |
| The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss | 17.2 | 0 | 1 |
| Assessment of hair loss: clinical relevance of hair growth evaluation methods | 17.2 | 0 | 1 |
| Cosmetics and hair loss | 17.2 | 0 | 1 |
| Frequency and associated factors of hair loss among patients with inflammatory bowel disease | 17.2 | 0 | 1 |
| Effective ingredients of school-based drug prevention programs. A systematic review | 17.2 | 0 | 1 |
| Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial | 17.2 | 0 | 1 |
| Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate? | 17.2 | 0 | 1 |
| Approach to hair loss in women of color | 17.2 | 0 | 1 |
| When your patient complains of hair loss | 17.2 | 0 | 1 |
| A patient with diffuse hair loss | 17.2 | 0 | 1 |
| Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss | 17.2 | 0 | 1 |
| Mouse models for human hair loss disorders | 17.2 | 0 | 1 |
| Toe tourniquet syndrome in association with maternal hair loss | 17.2 | 0 | 1 |
| The patient with hair loss | 17.2 | 0 | 1 |
| Hair loss after extracorporeal membrane oxygenation | 17.2 | 0 | 1 |
| Molecular mechanisms of chemotherapy-induced hair loss. | 17.2 | 0 | 1 |
| Frequency of Antinuclear Antibody Positivity in Patients with Pattern Hair Loss | 17.2 | 0 | 1 |
| Hair cosmetics: An overview | 17.2 | 0 | 1 |
| A 3-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of an Extra-Strength Marine Protein Supplement to Promote Hair Growth and Decrease Shedding in Women with Self-Perceived Thinning Hair | 17.2 | 0 | 1 |
| A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis | 17.2 | 0 | 1 |
| Development of an easy to use tool to assess HIV treatment readiness in adolescent clinical care settings | 17.2 | 0 | 1 |
| Hair loss induced by dopamine agonist: case report and review of the literature | 17.2 | 0 | 1 |
| Hair loss associated with escitalopram but not with venlafaxine: a case report | 17.2 | 0 | 1 |
| Optimal Management of Hair Loss (Alopecia) in Children | 17.2 | 0 | 1 |
| Hair care practices in African American women | 17.2 | 0 | 1 |
| The itchy scalp--scratching for an explanation. | 17.2 | 0 | 1 |
| Patches of hair loss on the scalp | 17.2 | 0 | 1 |
| Gloriosa superba ingestion: Hair loss and acute renal failure | 17.2 | 0 | 1 |
| Severe Hair Loss of the Scalp due to a Hair Dye Containing Para phenylenediamine | 17.2 | 0 | 1 |
| Hair loss remedies--separating fact from fiction. | 17.2 | 0 | 1 |
| Hair loss in a child associated with naproxen | 17.2 | 0 | 1 |
| Tinea capitis caused by Trichophyton tonsurans presenting as an obscure patchy hair loss due to daily antifungal shampoo use | 17.2 | 0 | 1 |
| Pharmacologic management of pattern hair loss | 17.2 | 0 | 1 |
| The treatment of female pattern hair loss and other applications of surgical hair restoration in women | 17.2 | 0 | 1 |
| Quantitative Evaluation of Female Pattern Hair Loss in Chinese Women: A Preliminary Study | 17.2 | 0 | 1 |
| Diseases on hair follicles leading to hair loss part I: nonscarring alopecias | 17.2 | 0 | 1 |
| Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia | 17.2 | 0 | 1 |
| Diseases on hair follicles leading to hair loss part II: scarring alopecias | 17.2 | 0 | 1 |
| Alopecia areata: autoimmune basis of hair loss. | 17.2 | 0 | 1 |
| Doppler laser imaging predicts response to topical minoxidil in the treatment of female pattern hair loss | 17.2 | 0 | 1 |
| Female pattern hair loss: Clinico-laboratory findings and trichoscopy depending on disease severity | 17.2 | 0 | 1 |
| Antigen presenting cells in the skin of a patient with hair loss and systemic lupus erythematosus | 17.2 | 0 | 1 |
| Cochrane plain language summaries are highly heterogeneous with low adherence to the standards | 17.2 | 0 | 1 |
| Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy | 17.2 | 0 | 1 |
| A Hospital-based Study to Determine Causes of Diffuse Hair Loss in Women | 17.2 | 0 | 1 |
| Management of hair loss | 17.2 | 0 | 1 |
| Diffuse Hair Loss Induced by Sertraline Use | 17.2 | 0 | 1 |
| A Critical Assessment of the Evidence for Low-Level Laser Therapy in the Treatment of Hair Loss | 17.2 | 0 | 1 |
| Hair loss and hyperprolactinemia in women | 17.2 | 0 | 1 |
| The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study | 17.2 | 0 | 1 |
| Efficacy of Finasteride 1.25 mg on Female Pattern Hair Loss; Pilot Study | 17.2 | 0 | 1 |
| Follicular unit transplantation for male and female pattern hair loss and restoring eyebrows | 17.2 | 0 | 1 |
| Weight Gain and Hair Loss during Anti-TNF Therapy | 17.2 | 0 | 1 |
| Trichoscopic Findings of Hair Loss in Koreans. | 17.2 | 0 | 1 |
| New Treatments for Hair Loss | 17.2 | 0 | 1 |
| Interventions for Female Pattern Hair Loss | 17.2 | 0 | 1 |
| Facial papules in fibrosing alopecia in a pattern distribution (cicatricial pattern hair loss) | 17.2 | 0 | 1 |
| Hair loss at injection sites of mesotherapy for alopecia | 17.2 | 0 | 1 |
| Severe scalp hair loss in a female patient with acromegaly treated with lanreotide autogel after unsuccessful surgery. | 17.2 | 0 | 1 |
| Diagnosis of Hair Loss: Clinical features of common causes of hair loss. | 17.2 | 0 | 1 |
| Rapqunzel no more. Hair loss in older women. | 17.2 | 0 | 1 |
| Differential diagnosis of hair loss in children | 17.2 | 0 | 1 |
| Low level light-minoxidil 5% combination versus either therapeutic modality alone in management of female patterned hair loss: A randomized controlled study. | 17.2 | 0 | 1 |
| The effect of autologous activated platelet-rich plasma injection on female pattern hair loss: A randomized placebo-controlled study. | 17.2 | 0 | 1 |
| A Randomized, Double-blind, Placebo-controlled, Multi-center, Extension Trial Evaluating the Efficacy of a New Oral Supplement in Women with Self-perceived Thinning Hair | 17.2 | 0 | 1 |
| Sensitive scalp | 17.2 | 0 | 1 |
| A Double-blind, Placebo-controlled Study Evaluating the Efficacy of an Oral Supplement in Women with Self-perceived Thinning Hair. | 17.2 | 0 | 1 |
| The diagnosis and treatment of iron deficiency and its potential relationship to hair loss | 17.2 | 0 | 1 |
| A marine protein-based dietary supplement for subclinical hair thinning/loss: Results of a multisite, double-blind, placebo-controlled clinical trial | 17.2 | 0 | 1 |
| Systematic reviews on child welfare services: identifying and disseminating the evidence | 17.2 | 0 | 1 |
| A powerful, yet easy to use, computerized analysis of competitive protein binding and radioimmunoassay data | 17.2 | 0 | 1 |
| Helping children cope with hair loss | 17.2 | 0 | 1 |
| t-Flavanone Improves the Male Pattern of Hair Loss by Enhancing Hair-Anchoring Strength: A Randomized, Double-Blind, Placebo-Controlled Study | 17.2 | 0 | 1 |
| Plain language: a strategic response to the health literacy challenge | 17.2 | 0 | 1 |
| Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature | 17.2 | 0 | 1 |
| Prognostic implications of qualitative assessment of left ventricular function compared to simple routine quantitative echocardiography | 17.2 | 0 | 1 |
| Serum drug level-related sodium valproate-induced hair loss | 17.2 | 0 | 1 |
| Environmental and cosmetic factors in hair loss and destruction | 17.2 | 0 | 1 |
| Iron Plays a Certain Role in Patterned Hair Loss | 17.2 | 0 | 1 |
| Hair Loss: A Harbinger of the Morbidities to Come! | 17.2 | 0 | 1 |
| Safety of hair products during pregnancy: personal use and occupational exposure | 17.2 | 0 | 1 |
| Hair loss with use of the levonorgestrel intrauterine device | 17.2 | 0 | 1 |
| Clinical practice. Hair loss in women | 17.2 | 0 | 1 |
| Healthy hair: what is it? | 17.2 | 0 | 1 |
| Female pattern hair loss: current treatment concepts | 17.2 | 0 | 1 |
| A patch of hair loss on the scalp | 17.2 | 0 | 1 |
| Hair loss and hair-pulling in rhesus macaques (Macaca mulatta) | 17.2 | 0 | 1 |
| An Intervention to Teach Physicians to Use Plain Language for After Visit Summaries | 17.2 | 0 | 1 |
| How to approach hair loss in women. | 17.2 | 0 | 1 |
| Identification of Centella asiatica's Effective Ingredients for Inducing the Neuronal Differentiation. | 17.2 | 0 | 1 |
| Finasteride 5 mg/day treatment of patterned hair loss in normo-androgenetic postmenopausal women | 17.2 | 0 | 1 |
| Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center | 17.2 | 0 | 1 |
| Serum Biotin Levels in Women Complaining of Hair Loss | 17.2 | 0 | 1 |
| Using plain language skills to create an educational brochure about sperm banking for adolescent and young adult males with cancer | 17.2 | 0 | 1 |
| Quality of life in women with female pattern hair loss and the impact of topical minoxidil treatment on quality of life in these patients | 17.2 | 0 | 1 |
| Adolescent hair loss | 17.2 | 0 | 1 |
| Serum Vitamin D3 Level in Patients with Female Pattern Hair Loss | 17.2 | 0 | 1 |
| Effect of the multifunctional cosmetic ingredient sphinganine on hair loss in males and females with diffuse hair reduction | 17.2 | 0 | 1 |
| Epidermal Nbn deletion causes premature hair loss and a phenotype resembling psoriasiform dermatitis | 17.2 | 0 | 1 |
| Effects of hair treatment on hair mercury—The best biomarker of methylmercury exposure? | 17.2 | 0 | 1 |
| Hair loss as a result of cutaneous autoimmunity: frontiers in the immunopathogenesis of primary cicatricial alopecia | 17.2 | 0 | 1 |
| Development of the Patient Education Materials Assessment Tool (PEMAT): A new measure of understandability and actionability for print and audiovisual patient information | 17.2 | 0 | 1 |
| Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice | 17.2 | 0 | 1 |
| Diffuse hair loss in an adult female: approach to diagnosis and management | 17.2 | 0 | 1 |
| Differential Diagnosis of Female-Pattern Hair Loss | 17.2 | 0 | 1 |
| Therapeutic role of human hepatocyte growth factor (HGF) in treating hair loss | 17.2 | 0 | 1 |
| Analysis of serum zinc and copper concentrations in hair loss | 17.2 | 0 | 1 |
| Androgens and hair loss | 17.2 | 0 | 1 |
| Diffuse hair loss: its triggers and management | 17.2 | 0 | 1 |
| Preparation and evaluation of a hair wax containing propolis and Eruca sativa seed oil for hair growth | 17.2 | 0 | 1 |
| Hair care practices in African-American patients | 17.2 | 0 | 1 |
| The difficult hair loss patient: A particular challenge | 17.2 | 0 | 1 |
| Vellus hairs in the frontal scalp in early female pattern hair loss. | 17.2 | 0 | 1 |
| Is Trichoscopy a reliable tool to diagnose early female pattern hair loss? | 17.2 | 0 | 1 |
| Application of the basic and specific classification on patterned hair loss in Indians | 17.2 | 0 | 1 |
| Hereditary hair loss and the ancient signaling pathways that regulate ectodermal appendage formation | 17.2 | 0 | 1 |
| Diet and hair loss: effects of nutrient deficiency and supplement use. | 17.2 | 0 | 1 |
| The Hair Shedding Visual Scale: A Quick Tool to Assess Hair Loss in Women. | 17.2 | 0 | 1 |
| Effect of Adiantum Capillus veneris Linn on an Animal Model of Testosterone-Induced Hair Loss | 17.2 | 0 | 1 |
| Erythroid Differentiation Regulator 1 as a Novel Biomarker for Hair Loss Disorders | 17.2 | 0 | 1 |
| Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems. | 17.2 | 0 | 1 |
| A Case Report of Cushing's Disease Presenting as Hair Loss | 17.2 | 0 | 1 |
| Hair loss in elderly women. | 17.2 | 0 | 1 |
| Hair loss in children: Common and uncommon causes; clinical and epidemiological study in Jordan | 17.2 | 0 | 1 |
| Content, Usability, and Utilization of Plain Language in Breast Cancer Mobile Phone Apps: A Systematic Analysis | 17.2 | 0 | 1 |
| The Female Pattern Hair Loss: Review of Etiopathogenesis and Diagnosis | 17.2 | 0 | 1 |
| Behenamidopropyl Dimethylamine: unique behaviour in solution and in hair care formulations | 17.2 | 0 | 1 |
| Finasteride treatment of hair loss in women | 17.2 | 0 | 1 |
| Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism | 17.2 | 0 | 1 |
| Chemotherapy-induced hair loss | 17.2 | 0 | 1 |
| Methods of hair loss evaluation in patients with endocrine disorders | 17.2 | 0 | 1 |
| Hair loss in long-term or home parenteral nutrition: are micronutrient deficiencies to blame? | 17.2 | 0 | 1 |
| Commentary: Iron deficiency and hair loss: problems with measurement of iron | 17.2 | 0 | 1 |
| The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome | 17.2 | 0 | 1 |
| Optimal techniques with the Diamondback 360° System achieve effective results for the treatment of peripheral arterial disease | 17.2 | 0 | 1 |
| Coexistence of giant blue nevus of the scalp with hair loss and alopecia areata. | 17.2 | 0 | 1 |
| Hair loss due to lichen planopilaris after hair transplantation: a report of two cases and a literature review | 17.2 | 0 | 1 |
| Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: an update of what we now know | 17.2 | 0 | 1 |
| Risk factors associated with hair loss, ulceration, and swelling at the hock in freestall-housed UK dairy herds. | 17.2 | 0 | 1 |
| Hair Loss in Autoimmune Cutaneous Bullous Disorders | 17.2 | 0 | 1 |
| Anticipatory coping: taking control of hair loss | 17.2 | 0 | 1 |
| Progress in the research of Radix Astragali in treating chronic heart failure: Effective ingredients, dose-effect relationship and adverse reaction | 17.2 | 0 | 1 |
| Congenital hair loss disorders: Rare, but not too rare | 17.2 | 0 | 1 |
| Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo. | 17.2 | 0 | 1 |
| Topical minoxidil for hair loss in women. | 17.2 | 0 | 1 |
| A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp health. | 17.2 | 0 | 1 |
| Hair loss in hospital medicine: a practical guide | 17.2 | 0 | 1 |
| A review of scalp camouflaging agents and prostheses for individuals with hair loss | 17.2 | 0 | 1 |
| Amiodarone-induced hair loss: case report and review of the literature: Table 1 | 17.2 | 0 | 1 |
| Treatment of female pattern hair loss | 17.2 | 0 | 1 |
| Histopathology of Scarring and Nonscarring Hair Loss | 17.2 | 0 | 1 |
| Drugs and hair loss | 17.2 | 0 | 1 |
| Autoimmune disease and hair loss | 17.2 | 0 | 1 |
| Hair: what is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment | 17.2 | 0 | 1 |
| Update on the Genetics of Androgenetic Alopecia, Female Pattern Hair Loss, and Alopecia Areata: Implications for Molecular Diagnostic Testing | 17.2 | 0 | 1 |
| Managing hair loss in midlife women | 17.2 | 0 | 1 |
| Pathobiology of chemotherapy-induced hair loss | 17.2 | 0 | 1 |
| Hair loss in patients with inflammatory bowel disease | 17.2 | 0 | 1 |
| Hair loss in the dermatology office: an update on alopecia areata | 17.2 | 0 | 1 |
| Hair loss and herbs for treatment | 17.2 | 0 | 1 |
| Management of Advanced Hair Loss Patterns | 17.2 | 0 | 1 |
| Female Hair Restoration | 17.2 | 0 | 1 |
| Scalp micropigmentation: a useful treatment for hair loss | 17.2 | 0 | 1 |
| Androgenetic alopecia (male pattern hair loss) in the United States: What treatments should primary care providers recommend? | 17.2 | 0 | 1 |
| Aromatase inhibitor therapy and hair loss among breast cancer survivors | 17.2 | 0 | 1 |
| Silicone oil emulsions: strategies to improve their stability and applications in hair care products | 17.2 | 0 | 1 |
| Regenerative medicine and hair loss: how hair follicle culture has advanced our understanding of treatment options for androgenetic alopecia. | 17.2 | 0 | 1 |
| Hair loss in infancy | 17.2 | 0 | 1 |
| Hair loss in autoimmune systemic diseases | 17.2 | 0 | 1 |
| A review of hair care products for black individuals | 17.2 | 0 | 1 |
| Evaluation and diagnosis of the hair loss patient: part I. History and clinical examination | 17.2 | 0 | 1 |
| Evaluation and diagnosis of the hair loss patient: part II. Trichoscopic and laboratory evaluations | 17.2 | 0 | 1 |
| Practitioner review: Effective ingredients of prevention programs for youth at risk of persistent juvenile delinquency--recommendations for clinical practice. | 17.2 | 0 | 1 |
| Genetics of human isolated hereditary hair loss disorders | 17.2 | 0 | 1 |
| Simple Public License | 17.2 | 0 | 1 |
| Degradation of the ethyl glucuronide content in hair by hydrogen peroxide and a non-destructive assay for oxidative hair treatment using infra-red spectroscopy | 17.2 | 0 | 1 |
| Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study | 17.2 | 0 | 1 |
| A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in Women With Female Pattern Hair Loss | 17.2 | 0 | 1 |
| 5% Minoxidil: treatment for female pattern hair loss | 17.2 | 0 | 1 |
| Plain language for interpreting in consulting rooms. | 17.2 | 0 | 1 |
| Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss | 17.2 | 0 | 1 |
| Alopecia Areata Progression Index, a Scoring System for Evaluating Overall Hair Loss Activity in Alopecia Areata Patients with Pigmented Hair: A Development and Reliability Assessment | 17.2 | 0 | 1 |
| Coexistence of Congenital Giant Melanocytic Nevus of the Scalp with Cranial Defect, Poliosis, and Hair Loss | 17.2 | 0 | 1 |
| Effect of stress and gentling on hair loss due to epidermal carcinogen painting | 17.2 | 0 | 1 |
| The scalp biopsy for hair loss and its interpretation | 17.2 | 0 | 1 |
| The Safety and Efficacy of a Sustainable Marine Extract for the Treatment of Thinning Hair: A Summary of New Clinical Research and Results from a Panel Discussion on the Problem of Thinning Hair and Current Treatments | 17.2 | 0 | 1 |
| Evaluation of Hair Loss | 17.2 | 0 | 1 |
| Hair Care and Dyeing | 17.2 | 0 | 1 |
| Easy to use and reliable technique for online dissolved oxygen tension measurement in shake flasks using infrared fluorescent oxygen-sensitive nanoparticles. | 17.2 | 0 | 1 |
| Hair loss. What causes it and what can be done about it. | 17.2 | 0 | 1 |
| Cancer‐related hair loss: a selective review of the alopecia research literature | 17.2 | 0 | 1 |
| Evaluation and Management of the Hair Loss Patient in the Primary Care Setting | 17.2 | 0 | 1 |
| Up-to-date Clinical Trials of Hair Regeneration using Conditioned Media of Adipose-Derived Stem Cells in Male and Female Pattern Hair Loss | 17.2 | 0 | 1 |
| Identification of an easy to use 3D culture model to investigate invasion and anticancer drug response in chondrosarcomas | 17.2 | 0 | 1 |
| Plain Language Summary: Otitis Media with Effusion | 17.2 | 0 | 1 |
| Side Effects Related to 5 α-Reductase Inhibitor Treatment of Hair Loss in Women: A Review | 17.2 | 0 | 1 |
| Systemic causes of hair loss. | 17.2 | 0 | 1 |
| Diagnosis and management of hair loss in children | 17.2 | 0 | 1 |
| The use of scalp cooling for chemotherapy-induced hair loss | 17.2 | 0 | 1 |
| Autologous Platelet-Rich Plasma for the Treatment of Pattern Hair Loss | 17.2 | 0 | 1 |
| Effective ingredients of verbal de-escalation: validating an English modified version of the 'De-Escalating Aggressive Behaviour Scale'. | 17.2 | 0 | 1 |
| The Role of Hair Loss in Cancer Identity: Perceptions of Chemotherapy-Induced Alopecia Among Women Treated for Early-Stage Breast Cancer or Ductal Carcinoma in Situ. | 17.2 | 0 | 1 |
| Development of Plain Language Supplemental Materials for the Biobank Informed Consent Process | 17.2 | 0 | 1 |
| Late-onset robust curly hair growth in a patient with BRAF-mutated metastatic melanoma responding to dabrafenib | 17.2 | 0 | 1 |
| Mechanism of action of herbs and their active constituents used in hair loss treatment | 17.2 | 0 | 1 |
| The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study. | 17.2 | 0 | 1 |
| Efficacy and safety of 5% minoxidil topical foam in male pattern hair loss treatment and patient satisfaction. | 17.2 | 0 | 1 |
| Association of metabolic syndrome with female pattern hair loss in women: A case-control study | 17.2 | 0 | 1 |
| Beardbrand | 17.2 | 0 | 1 |
| Simultaneous Quantification of Dexpanthenol and Resorcinol from Hair Care Formulation Using Liquid Chromatography: Method Development and Validation | 17.2 | 0 | 1 |
| The computer program structure for assigning individuals to populations: easy to use but easier to misuse. | 17.2 | 0 | 1 |
| Peek | 17.2 | 0 | 1 |
| Platelet rich plasma for treatment of non-scarring hair loss: systematic review of literature | 17.2 | 0 | 1 |
| Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl | 17.2 | 0 | 1 |
| Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss | 17.2 | 0 | 1 |
| Genetics and other factors in the aetiology of female pattern hair loss | 17.2 | 0 | 1 |
| Diffuse hair loss and psychiatric disturbance | 17.2 | 0 | 1 |
| Hydrogen peroxide and monoethanolamine are the key causative ingredients for hair dye-induced dermatitis and hair loss | 17.2 | 0 | 1 |
| Self-reported hair loss in patients with chronic spontaneous urticaria treated with omalizumab: an under-reported, transient side effect? | 17.2 | 0 | 1 |
| Topically used herbal products for the treatment of hair loss: preclinical and clinical studies | 17.2 | 0 | 1 |
| The adapted classification of male pattern hair loss improves reliability. | 17.2 | 0 | 1 |
| Do hair care practices affect the acquisition of tinea capitis? A case-control study | 17.2 | 0 | 1 |
| Hormone-containing hair product use in prepubertal children | 17.2 | 0 | 1 |
| A simple routine method for detecting hidden rheumatoid factors | 17.2 | 0 | 1 |
| Parent health literacy and satisfaction with plain language education materials in a pediatric surgery outpatient clinic: a pilot study | 17.2 | 0 | 1 |
| Hair loss in the female | 17.2 | 0 | 1 |
| Hair loss in systemic disease. | 17.2 | 0 | 1 |
| Aetiology and pathophysiology of hair loss | 17.2 | 0 | 1 |
| Asthma: in plain language | 17.2 | 0 | 1 |
| Hair loss among elderly men: etiology and impact on perceived age. | 17.2 | 0 | 1 |
| Comparison of permanent hair loss in children with standard risk PNETS of the posterior fossa following radiotherapy alone or chemotherapy and radiotherapy after surgical resection | 17.2 | 0 | 1 |
| Quantification of female pattern hair loss: a study in a Turkish population. | 17.2 | 0 | 1 |
| Citalopram and Hair Loss | 17.2 | 0 | 1 |
| Use of the TrichoScan to assess female pattern hair loss | 17.2 | 0 | 1 |
| Hair loss and plaquelike skin lesions. | 17.2 | 0 | 1 |
| A Case Report of Fluoxetine- and Venlafaxine-Induced Hair Loss | 17.2 | 0 | 1 |
| Usefulness of TrichoScan professional in the evaluation of hair loss in females. Report of 180 cases | 17.2 | 0 | 1 |
| Attitudes, behaviors, and expectations of men seeking medical treatment for male pattern hair loss: results of a multinational survey | 17.2 | 0 | 1 |
| Effects of a new mild shampoo for preventing hair loss in Asian by a simple hand-held phototrichogram technique. | 17.2 | 0 | 1 |
| A Novel Neonatal Feeding Intolerance and Necrotizing Enterocolitis Risk-Scoring Tool Is Easy to Use and Valued by Nursing Staff | 17.2 | 0 | 1 |
| An immune regulatory CCT repeat containing oligodeoxynucleotide capable of causing hair loss in male mice | 17.2 | 0 | 1 |
| Dermal fibrosis in male pattern hair loss: a suggestive implication of mast cells. | 17.2 | 0 | 1 |
| Hair product use and breast cancer risk among African American and White women | 17.2 | 0 | 1 |
| Sex Hormones and Hair Loss in Men From the General Population of Northeastern Germany | 17.2 | 0 | 1 |
| Clinical Evidence of Increase in Hair Growth and Decrease in Hair Loss without Adverse Reactions Promoted by the Commercial Lotion ECOHAIR®. | 17.2 | 0 | 1 |
| Alopecia scoring: the quantitative assessment of hair loss in captive macaques. | 17.2 | 0 | 1 |
| Preventing hair loss during adriamycin therapy | 17.2 | 0 | 1 |
| Behaviour evaluation for risk-taking adolescents (BERTA): an easy to use and assess instrument to detect adolescent risky behaviours in a clinical setting | 17.2 | 0 | 1 |
| In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss. | 17.2 | 0 | 1 |
| Hair loss in internal medical illnesses | 17.2 | 0 | 1 |
| Hair care practices and structural evaluation of scalp and hair shaft parameters in African American and Caucasian women | 17.2 | 0 | 1 |
| Drug-induced hair loss and hair growth. Incidence, management and avoidance | 17.2 | 0 | 1 |
| Polymorphic CAG Repeat Numbers in the Androgen Receptor Gene of Female Pattern Hair Loss in a Han Chinese Population | 17.2 | 0 | 1 |
| Hair loss in patients with skin of color | 17.2 | 0 | 1 |
| Enhancing Communication Related to Symptom Management Through Plain Language. | 17.2 | 0 | 1 |
| Young man with unexplained hair loss | 17.2 | 0 | 1 |
| Alopecia. III. Diffuse hair loss (nonscarring). | 17.2 | 0 | 1 |
| Both low circulating insulin-like growth factor-1 and high-density lipoprotein cholesterol are associated with hair loss in middle-aged women. | 17.2 | 0 | 1 |
| Management of hair loss in women. | 17.2 | 0 | 1 |
| Does interleukin-1 induce hair loss? | 17.2 | 0 | 1 |
| Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss | 17.2 | 0 | 1 |
| The itchy scalp and other pruritic curiosities | 17.2 | 0 | 1 |
| Evaluation of the severity and triggering factors of sensitive scalp in Chinese females | 17.2 | 0 | 1 |
| Plain Language Summary: Adult Sinusitis (Sinus Infection). | 17.2 | 0 | 1 |
| A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents. | 17.2 | 0 | 1 |
| Hair loss associated with long-term sertraline treatment in teenager | 17.2 | 0 | 1 |
| Classification of Male-pattern Hair Loss | 17.2 | 0 | 1 |
| Prevalence of Nutritional Deficiencies in Hair Loss among Indian Participants: Results of a Cross-sectional Study | 17.2 | 0 | 1 |
| Essentials of hair care often neglected: Hair cleansing | 17.2 | 0 | 1 |
| The 3D-CAM provides a brief, easy to use, sensitive and specific delirium assessment tool for older hospitalised patients, both with and without dementia | 17.2 | 0 | 1 |
| A Study on Scalp Hair Health and Hair Care Practices among Malaysian Medical Students | 17.2 | 0 | 1 |
| Medical records: an easy to use A4 age/sex filing system. | 17.2 | 0 | 1 |
| A simple routine for optic disc photography through a natural pupil. Short communication | 17.2 | 0 | 1 |
| New advance in studies on antimicrobal activity of Scutellaria baicalensis and its effective ingredients | 17.2 | 0 | 1 |
| Association of Single Nucleotide Polymorphisms in the CYP19A1 Gene with Female Pattern Hair Loss in a Chinese Population | 17.2 | 0 | 1 |
| Mouse models for the study of human hair loss | 17.2 | 0 | 1 |
| Hair loss | 17.2 | 0 | 1 |
| The development and validation of an easy to use automatic QT-interval algorithm. | 17.2 | 0 | 1 |
| Hair loss in a 5-year-old boy. Tinea capitis caused by Microsporum gypseum | 17.2 | 0 | 1 |
| Area of hock hair loss in dairy cows: risk factors and correlation with a categorical scale. | 17.2 | 0 | 1 |
| Stigma of hair loss after chemotherapy | 17.2 | 0 | 1 |
| Hair Loss After Routine Immunizations | 17.2 | 0 | 1 |
| Frequency of body dysmorphic disorder among patients with complaints of hair loss | 17.2 | 0 | 1 |
| NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD. | 17.2 | 0 | 1 |
| Evaluation of human exposure to metals from some commonly used hair care products in Nigeria | 17.2 | 0 | 1 |
| Hair loss after varicella zoster virus infection. | 17.2 | 0 | 1 |
| Scalp lesions and hair loss. | 17.2 | 0 | 1 |
| Transient Hair Loss after Finger Replantation | 17.2 | 0 | 1 |
| Individual differences in men's perceptions of and reactions to thinning hair | 17.2 | 0 | 1 |
| Diffuse hair loss in women | 17.2 | 0 | 1 |
| Study roadmap for high-throughput development of easy to use and affordable biomarkers as diagnostics for tropical diseases: a focus on malaria and schistosomiasis | 17.2 | 0 | 1 |
| Isolated Body Hair Loss: An Unusual Presentation of Lichen Planopilaris | 17.2 | 0 | 1 |
| The human orthologue of murine Mpzl3 with predicted adhesive and immune functions is a potential candidate gene for immune-related hereditary hair loss | 17.2 | 0 | 1 |
| Dry milks are easy to use, easy to store and an insurance against emergencies. | 17.2 | 0 | 1 |
| Diffuse scalp hair loss due to levothyroxine overdose | 17.2 | 0 | 1 |
| A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine | 17.2 | 0 | 1 |
| Brief Summary in Plain Language of the Most Important Laws Concerning Women | 17.2 | 0 | 1 |
| The Philippine hair wax spiders and their relatives: revision of the Pholcus bicornutus species group (Araneae, Pholcidae) | 17.2 | 0 | 1 |
| XNBC V9: a simulation package of biological neural networks for the neurobiologist, easy to use, full featured and extensible | 17.2 | 0 | 1 |
| Basaloid follicular hamartoma, total body hair loss and SLE | 17.2 | 0 | 1 |
| Hair loss and Hedgehog inhibitors: a class effect? | 17.2 | 0 | 1 |
| Mobilizing transit-amplifying cell-derived ectopic progenitors prevents hair loss from chemotherapy or radiation therapy | 17.2 | 0 | 1 |
| Formulation and evaluation of polyherbal hair care powders | 17.2 | 0 | 1 |
| Diffuse scalp hair loss due to levothyroxine overdose | 17.2 | 0 | 1 |
| British Medical Association pitches for end to management speak, urges use of plain language | 17.2 | 0 | 1 |
| A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy | 17.2 | 0 | 1 |
| Human scalp irritation compared to that of the arm and back | 17.2 | 0 | 1 |
| The effect of hair loss on quality of life | 17.2 | 0 | 1 |
| DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0. | 17.2 | 0 | 1 |
| Drug induced hair loss | 17.2 | 0 | 1 |
| Localized hair loss in an elderly man. | 17.2 | 0 | 1 |
| A Case of Mirtazapine-Associated Hair Loss | 17.2 | 0 | 1 |
| Treating young men with hair loss | 17.2 | 0 | 1 |
| Evaluation of pH of Bathing Soaps and Shampoos for Skin and Hair Care | 17.2 | 0 | 1 |
| NucBase, an easy to use read mapper for small RNAs | 17.2 | 0 | 1 |
| Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study | 17.2 | 0 | 1 |
| Female pattern hair loss in a patient with 17alpha-hydroxylase deficiency. | 17.2 | 0 | 1 |
| Contact allergic dermatitis to quinine in an anti-hair loss lotion | 17.2 | 0 | 1 |
| Allergic contact dermatitis from carvone in hair conditioners | 17.2 | 0 | 1 |
| Quantification of Sunscreen Benzophenone-4 in Hair Shampoos by Hydrophilic Interactions Thin-Layer Chromatography/Densitometry or Derivative UV Spectrophotometry. | 17.2 | 0 | 1 |
| Commentary: healthy hair and protein loss | 17.2 | 0 | 1 |
| A simple routine for quantitative analysis of light and dark kinetics of photochemical and non-photochemical quenching of chlorophyll fluorescence in intact leaves | 17.2 | 0 | 1 |
| Involvement of substance P and the neurokinin-1 receptor in radiation-induced hair loss in mice | 17.2 | 0 | 1 |
| Amiodarone and hair loss | 17.2 | 0 | 1 |
| Simple and rapid analytical method for the simultaneous determination of cetrimonium chloride and alkyl alcohols in hair conditioners | 17.2 | 0 | 1 |
| Non-thermal extraction of effective ingredients from Schisandra chinensis Baill and the antioxidant activity of its extract | 17.2 | 0 | 1 |
| Occipital involvement in female pattern hair loss: histopathological evidences | 17.2 | 0 | 1 |
| Photosensitivity to musk ambrette in a toilet soap and hair gel. | 17.2 | 0 | 1 |
| Characterization of yield stress and slip behaviour of skin/hair care gels using steady flow and LAOS measurements and their correlation with sensorial attributes | 17.2 | 0 | 1 |
| Severe hair loss associated with fluoxetine use. | 17.2 | 0 | 1 |
| Cancer research. Preventing hair loss from chemotherapy | 17.2 | 0 | 1 |
| Qualification of an automated device to objectively assess the effect of hair care products on hair shine | 17.2 | 0 | 1 |
| Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups | 17.2 | 0 | 1 |
| Hair follicle differentiation: expression, structure and evolutionary conservation of the hair type II keratin intermediate filament gene family | 17.2 | 0 | 1 |
| Hair loss in children and adolescents | 17.2 | 0 | 1 |
| Radiography of the upper ankle using a fixation device --a simple routine examination? | 17.2 | 0 | 1 |
| Hair product use in systemic lupus erythematosus. A case-control study | 17.2 | 0 | 1 |
| Venlafaxine-induced hair loss | 17.2 | 0 | 1 |
| Letter: Profuse hair loss | 17.2 | 0 | 1 |
| Hair loss after prolonged EEG/video monitoring | 17.2 | 0 | 1 |
| Chemo-induced hair loss: prevention of a distressing side-effect | 17.2 | 0 | 1 |
| Hair loss after terbinafine treatment | 17.2 | 0 | 1 |
| Finasteride improves male pattern hair loss in a randomized study in identical twins | 17.2 | 0 | 1 |
| A standard measure of persistent bodily pain that is quick and easy to use, valid and stable over time | 17.2 | 0 | 1 |
| Shampoos and hair conditioners | 17.2 | 0 | 1 |
| Hair Care Practices as a Barrier to Physical Activity in African American Women | 17.2 | 0 | 1 |
| My hair is thinning on the top of my head. What treatments are available for hair loss in women? | 17.2 | 0 | 1 |
| Aromatase inhibitors induce 'male pattern hair loss' in women? | 17.2 | 0 | 1 |
| Black-dot tinea capitis. Patchy hair loss is common in pediatric patients | 17.2 | 0 | 1 |
| Does introduction of new "easy to use" inhalational devices improve medical personnel's knowledge of their proper use? | 17.2 | 0 | 1 |
| Hair Loss Associated with Fluoxetine Treatment | 17.2 | 0 | 1 |
| Iron status in diffuse telogen hair loss among women | 17.2 | 0 | 1 |
| Metal Sensitivity After TKA Presenting With Systemic Dermatitis and Hair Loss | 17.2 | 0 | 1 |
| Diffuse hair loss in women | 17.2 | 0 | 1 |
| Three cases of hair loss analyzed by the point of view of the analytical psychology | 17.2 | 0 | 1 |
| Hair loss and serum zinc values among Arab females in Al Ain region, United Arab Emirates | 17.2 | 0 | 1 |
| Inducible, reversible hair loss in transgenic mice | 17.2 | 0 | 1 |
| Radiation-induced temporary hair loss after endovascular embolization of the cerebral arteries: six cases | 17.2 | 0 | 1 |
| Generalized hair loss induced by indinavir plus ritonavir therapy | 17.2 | 0 | 1 |
| Methods of hair loss evaluation: a comparison of TrichoScan(®) with the modified wash test. | 17.2 | 0 | 1 |
| Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy | 17.2 | 0 | 1 |
| Pantogar--modern treatment of hair loss, structural hair lesions, early alopecia, and dystrophy of nails | 17.2 | 0 | 1 |
| Olanzapine-induced hair loss | 17.2 | 0 | 1 |
| Effect of hair care and hair cosmetics on the concentrations of fatty acid ethyl esters in hair as markers of chronically elevated alcohol consumption | 17.2 | 0 | 1 |
| Growth factor receptors and hair loss | 17.2 | 0 | 1 |
| Accounting for intended use application in characterizing the contributions of cyclopentasiloxane (D5) to aquatic loadings following personal care product use: Antiperspirants, skin care products and hair care products | 17.2 | 0 | 1 |
| Investigation of six novel susceptibility loci for male androgenetic alopecia in women with female pattern hair loss | 17.2 | 0 | 1 |
| Association between smoking and hair loss: another opportunity for health education against smoking? | 17.2 | 0 | 1 |
| Determination of the coordination environment of Cu(II) in human hair and its possible relevance to health and hair care treatments | 17.2 | 0 | 1 |
| Histopathological insights into hair loss in Cronkhite-Canada syndrome: diffuse anagen-telogen conversion precedes clinical hair loss progression | 17.2 | 0 | 1 |
| Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss | 17.2 | 0 | 1 |
| Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). | 17.2 | 0 | 1 |
| Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study | 17.2 | 0 | 1 |
| Clinical experiences derived from implementation of an easy to use concept for treatment of wound healing by secondary intention and guidance in selection of appropriate dressings | 17.2 | 0 | 1 |
| Hair loss in three patients with acromegaly treated with octreotide | 17.2 | 0 | 1 |
| Hair loss | 17.2 | 0 | 1 |
| Carbamazepine-induced hair loss | 17.2 | 0 | 1 |
| A newborn with hair loss | 17.2 | 0 | 1 |
| Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss). | 17.2 | 0 | 1 |
| Hair loss after rhytidectomy | 17.2 | 0 | 1 |
| Hair loss in an HIV-1 infected woman receiving lopinavir plus ritonavir therapy as first line HAART. | 17.2 | 0 | 1 |
| Hair loss, a triviality? | 17.2 | 0 | 1 |
| Increasing Intention to Comply with Pharmaceutical Product Instructions: An Exploratory Study Investigating the Rolesof Frame and Plain Language | 17.2 | 0 | 1 |
| Sick or made sick? Recurrent episodes of cutaneous and subcutaneous ulcers, colitis, arthralgia and hair loss... a systemic disease or iatrogenic? | 17.2 | 0 | 1 |
| Circumscribed scalp hair loss following multiple hair-cutter ant invasion | 17.2 | 0 | 1 |
| Evidence of hair loss after subacute exposure to 2-chloroethyl ethyl sulfide, a mustard analog, and beneficial effects of N-acetyl cysteine | 17.2 | 0 | 1 |
| Hair loss during lithium therapy | 17.2 | 0 | 1 |
| A case of hair loss induced by carbamazepine | 17.2 | 0 | 1 |
| Reply to: ‘Severe diffuse non‐scarring hair loss in systemic lupus erythematosus – clinical and histopathological analysis of four cases’ | 17.2 | 0 | 1 |
| Finasteride in the treatment of Japanese men with male pattern hair loss | 17.2 | 0 | 1 |
| Plain Language Summary: Earwax (Cerumen Impaction) | 17.2 | 0 | 1 |
| Plain Language Summary: Improving Nasal Form and Function after Rhinoplasty | 17.2 | 0 | 1 |
| Plain Language Summary: Benign Paroxysmal Positional Vertigo | 17.2 | 0 | 1 |
| Bandlike frontal hair loss in a 62-year-old woman | 17.2 | 0 | 1 |
| Serum Ferritin and Vitamin D in Female Hair Loss: Do They Play a Role? | 17.2 | 0 | 1 |
| Plain Language Summary: Evaluation of the Neck Mass in Adults | 17.2 | 0 | 1 |
| Can alopecia areata be triggered by emotional stress? An uncontrolled evaluation of 178 patients with extensive hair loss | 17.2 | 0 | 1 |
| Diffuse alopecia areata is associated with intense inflammatory infiltration and CD8+ T cells in hair loss regions and an increase in serum IgE level | 17.2 | 0 | 1 |
| Patchy hair loss on the pubis--a case study | 17.2 | 0 | 1 |
| Lung cancer-associated scalp hair loss: a rare cause of secondary alopecia neoplastica | 17.2 | 0 | 1 |
| Researchers link early hair loss and prostate cancer | 17.2 | 0 | 1 |
| The tractiophototrichogram, an objective method for evaluating hair loss | 17.2 | 0 | 1 |
| Evaluation of ivermectin for treatment of hair loss syndrome in black-tailed deer | 17.2 | 0 | 1 |
| Torsional method for evaluating hair damage and performance of hair care ingredients. | 17.2 | 0 | 1 |
| Correlates of hair loss in adult women of African descent in London, U.K.: findings of a cross-sectional study | 17.2 | 0 | 1 |
| Growth retardation and hair loss in transgenic mice overexpressing human H-ferritin gene | 17.2 | 0 | 1 |
| Evaluation and treatment of male and female pattern hair loss | 17.2 | 0 | 1 |
| The effect of CD34+ cell-containing autologous platelet-rich plasma injection on pattern hair loss: a preliminary study | 17.2 | 0 | 1 |
| Hair loss and cardiovascular health | 17.2 | 0 | 1 |
| Intermittent hair loss in a child with PIBI(D)S syndrome and trichothiodystrophy with defective DNA repair-xeroderma pigmentosum group D. | 17.2 | 0 | 1 |
| Effects of topical application of growth factors followed by microneedle therapy in women with female pattern hair loss: A pilot study | 17.2 | 0 | 1 |
| Design and Application of an Easy to Use Oligonucleotide Mass Calculation Program | 17.2 | 0 | 1 |
| Answer to: ‘Reply to: Severe diffuse non‐scarring hair loss in systemic lupus erythematosus – clinical and histopathological analysis of four cases’ | 17.2 | 0 | 1 |
| ChatterGrabber: A Lightweight Easy to Use Social Media SurveillanceToolkit. | 17.2 | 0 | 1 |
| An Easy to Use Tool for Creating and Maintaining User Dialogs | 17.2 | 0 | 1 |
| Treating young men with hair loss. | 17.2 | 0 | 1 |
| PS1-63: PRISM Online Training: A Free, Customized, Effective Plain Language Tutorial for Researchers. | 17.2 | 0 | 1 |
| Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases | 17.2 | 0 | 1 |
| Drug points: Hair loss during itraconazole treatment | 17.2 | 0 | 1 |
| Real-world use of scalp cooling to reduce chemotherapy-related hair loss | 17.2 | 0 | 1 |
| Hair loss associated with clonazepam | 17.2 | 0 | 1 |
| Hair loss in pityriasis versicolor lesions: A descriptive clinicopathological study | 17.2 | 0 | 1 |
| Successful treatment of female-pattern hair loss with spironolactone in a 9-year-old girl | 17.2 | 0 | 1 |
| Abstract: Stromal Vascular Fraction Enhanced Adipose Transplantation in Hair Loss: Early Experience & Active Phase II FDA Investigation. | 17.2 | 0 | 1 |
| Study on correlation between effective ingredients of dogwood fruit from genuine producing regions and traits | 17.2 | 0 | 1 |
| Factors associated with female pattern hair loss and its prevalence in Taiwanese women: A community-based survey | 17.2 | 0 | 1 |
| Effect of hairpieces on perceived quality of life in female pattern hair loss patients: questionnaire based study | 17.2 | 0 | 1 |
| Central hair loss in African American women: Incidence and potential risk factors | 17.2 | 0 | 1 |
| Reliability of the pattern hair loss classifications: A comparison of the basic and specific and Norwood–Hamilton classifications | 17.2 | 0 | 1 |
| A safe, effective, and easy to use warfarin initiation dosing nomogram for post-joint arthroplasty patients | 17.2 | 0 | 1 |
| Hair care and hair styles in women in Bamako, Mali | 17.2 | 0 | 1 |
| Flow injection analysis of zinc pyrithione in hair care products on a cobalt phthalocyanine modified screen-printed carbon electrode | 17.2 | 0 | 1 |
| A primer to natural hair care practices in black patients | 17.2 | 0 | 1 |
| Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy | 17.2 | 0 | 1 |
| Concurrence of palmoplantar psoriasiform eruptions and hair loss during carbamazepine treatment | 17.2 | 0 | 1 |
| Treatment of female pattern hair loss with oral antiandrogens | 17.2 | 0 | 1 |
| Love and Sex in Plain Language | 17.2 | 0 | 1 |
| Most Black women have a regular source of hair care--but not medical care | 17.2 | 0 | 1 |
| Sertraline-associated hair loss. | 17.2 | 0 | 1 |
| High-performance liquid chromatography-diode array and electrospray-mass spectrometry analysis of non-allowed substances in cosmetic products for preventing hair loss and other hormone-dependent skin diseases | 17.2 | 0 | 1 |
| Technique of spinal cord compression induced by inflation of epidural balloon catheter in rabbits (Oryctologus cuniculus): efficient and easy to use model. | 17.2 | 0 | 1 |
| Simultaneous analysis of anionic, amphoteric, nonionic and cationic surfactant mixtures in shampoo and hair conditioner by RP-HPLC/ELSD and LC/MS. | 17.2 | 0 | 1 |
| Causes of hair loss and the developments in hair rejuvenation | 17.2 | 0 | 1 |
| Rheological characterization of hair shampoo in the presence of dead sea salt | 17.2 | 0 | 1 |
| Characterization of hair styling formulations targeted to specific multicultural needs | 17.2 | 0 | 1 |
| Suitability of hair type for dermatophytes perforation and differential diagnosis of T. mentagrophytes from T. verrucosum. | 17.2 | 0 | 1 |
| What if scalp flora was involved in sensitive scalp onset? | 17.2 | 0 | 1 |
| Assays on nutrient and effective ingredients in different parts of Cordyceps militaris | 17.2 | 0 | 1 |
| Hair Care for the Black Patient | 17.2 | 0 | 1 |
| Ground substrate affects activity budgets and hair loss in outdoor captive groups of rhesus macaques (Macaca mulatta). | 17.2 | 0 | 1 |
| Oral phenytoin protects against experimental cyclophosphamide-chemotherapy induced hair loss | 17.2 | 0 | 1 |
| Hospital alcohol tests not completely easy to use for legal purposes. Conversion of ethanol levels in plasma or serum to permillage level in blood | 17.2 | 0 | 1 |
| Severe diffuse non‐scarring hair loss in systemic lupus erythematosus – clinical and histopathological analysis of four cases | 17.2 | 0 | 1 |
| Hair care in the black patient | 17.2 | 0 | 1 |
| Ethnic hair care products may increase false positives in hair drug testing | 17.2 | 0 | 1 |
| Hair care practices in diverse populations: what makes the difference? | 17.2 | 0 | 1 |
| Can adding oil control domain formation in binary amphiphile bilayers? | 17.2 | 0 | 1 |
| Hair loss perception and symptoms of depression in female outpatients attending a general dermatology clinic | 17.2 | 0 | 1 |
| Separation and determination of basic dyes formulated in hair care products by capillary electrophoresis | 17.2 | 0 | 1 |
| A novel missense mutation in the mouse hairless gene causes irreversible hair loss: genetic and molecular analyses of Hr m1Enu | 17.2 | 0 | 1 |
| Visible-to-Near IR Quantum Dot–Based Hypermulticolor High-Content Screening of Herbal Medicines for the Efficacy Monitoring of Hair Growth Promotion and Hair Loss Inhibition | 17.2 | 0 | 1 |
| Racial/ethnic differences in hormonally-active hair product use: a plausible risk factor for health disparities | 17.2 | 0 | 1 |
| Endeavors to make the photophore, diazirine easy to use | 17.2 | 0 | 1 |
| The treatment of female pattern hair loss | 17.2 | 0 | 1 |
| Hair and Scalp Care in African American Women Who Exercise | 17.2 | 0 | 1 |
| Hair product use, age at menarche and mammographic breast density in multiethnic urban women | 17.2 | 0 | 1 |
| Follicular Cell Implantation: An Emerging Cell Therapy for Hair Loss. | 17.2 | 0 | 1 |
| Aryl hydrocarbon receptor overexpression in miniaturized follicles in female pattern hair loss. | 17.2 | 0 | 1 |
| Transgenic mice display hair loss and regrowth overexpressing mutant Hr gene | 17.2 | 0 | 1 |
| No difference in knowledge obtained from infographic or plain language summary of a Cochrane systematic review: three randomized controlled trials | 17.2 | 0 | 1 |
| A low-cost phantom for simple routine testing of single photon emission computed tomography (SPECT) cameras | 17.2 | 0 | 1 |
| Baldness may be caused by the weight of the scalp: gravity as a proposed mechanism for hair loss | 17.2 | 0 | 1 |
| Social and cultural dimensions of hair loss in women treated for breast cancer | 17.2 | 0 | 1 |
| Effective Results With Botulinum Toxin in Cerebral Palsy | 17.2 | 0 | 1 |
| Hair Loss With Rapid Weight Loss | 17.2 | 0 | 1 |
| Letter: Hair loss with rapid weight loss | 17.2 | 0 | 1 |
| A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss | 17.2 | 0 | 1 |
| Parietal scalp is another affected area in female pattern hair loss: an analysis of hair density and hair diameter | 17.2 | 0 | 1 |
| Effect of camouflaging agents on psychologic well-being: A cross-sectional survey of hair loss patients | 17.2 | 0 | 1 |
| Transient hair loss in patients with chronic spontaneous urticaria treated with omalizumab | 17.2 | 0 | 1 |
| Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone | 17.2 | 0 | 1 |
| 5α-Reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss | 17.2 | 0 | 1 |
| Is hair loss a reality in neuro-interventional radiology? | 17.2 | 0 | 1 |
| The effect of plasma rich in growth factors combined with follicular unit extraction surgery for the treatment of hair loss: A pilot study. | 17.2 | 0 | 1 |
| Comments on "Ethnic Hair Care Products May Increase False Positives in Hair Drug Testing" by Kidwell et al. | 17.2 | 0 | 1 |
| New Insight Into the Pathophysiology of Hair Loss Trigger a Paradigm Shift in the Treatment Approach | 17.2 | 0 | 1 |
| Focal Atrichia: A Diagnostic Clue in Female Pattern Hair Loss | 17.2 | 0 | 1 |
| A Case Report of Biotin Treatment for Valproate-Induced Hair Loss | 17.2 | 0 | 1 |
| Plain Language and Health Literacy for the Oncology Family Caregiver: Examining an English/Spanish mHealth Resource | 17.2 | 0 | 1 |
| A 6-month, randomized, double-blind, placebo-controlled study evaluating the ability of a marine complex supplement to promote hair growth in men with thinning hair | 17.2 | 0 | 1 |
| Design and evaluation of cryodevice, an easy to use apparatus for maintenance of optimum temperature during cryoglobulin assay. | 17.2 | 0 | 1 |
| Aberrant C nerve fibre function of the healthy scalp. | 17.2 | 0 | 1 |
| Scipion web tools: Easy to use cryo-EM image processing over the web. | 17.2 | 0 | 1 |
| A possible solution for hair loss by inhibiting corticotropin-releasing factor (CRF) receptor from traditional Chinese medicine | 17.2 | 0 | 1 |
| Development of a sensitive, generic and easy to use organophosphate skin disclosure kit. | 17.2 | 0 | 1 |
| Seasonality of hair loss: a time series analysis of Google Trends data 2004 to 2016. | 17.2 | 0 | 1 |
| Picking an ePCR. Functional systems should be convenient, reliable & easy to use | 17.2 | 0 | 1 |
| Lamotrigine Induces Hair Loss in a Patient With Treatment-Resistant Major Depressive Disorder | 17.2 | 0 | 1 |
| Parlux | 17.2 | 0 | 1 |
| Growing evidence of the beneficial effects of a marine protein-based dietary supplement for treating hair loss | 17.2 | 0 | 1 |
| The ovariectomized mouse simulates the pathophysiology of postmenopausal female pattern hair loss. | 17.2 | 0 | 1 |
| The cross-section trichometer: a new device for measuring hair quantity, hair loss, and hair growth | 17.2 | 0 | 1 |
| Platelet-Rich Plasma for the Treatment of Female Pattern Hair Loss: A Patient Survey | 17.2 | 0 | 1 |
| Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss | 17.2 | 0 | 1 |
| Diffuse scarring alopecia in a female pattern hair loss distribution | 17.2 | 0 | 1 |
| Design, Implementation, and Wide Pilot Deployment of FitForAll: An Easy to use Exergaming Platform Improving Physical Fitness and Life Quality of Senior Citizens. | 17.2 | 0 | 1 |
| Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil | 17.2 | 0 | 1 |
| Hair product artifact in magnetic resonance imaging. | 17.2 | 0 | 1 |
| Establishing and prioritizing research questions for the prevention, diagnosis and treatment of hair loss (excluding alopecia areata): the Hair Loss Priority Setting Partnership. | 17.2 | 0 | 1 |
| Towards a consensus on how to diagnose and quantify female pattern hair loss - The 'Female Pattern Hair Loss Severity Index (FPHL-SI)'. | 17.2 | 0 | 1 |
| Russian translations for Cochrane | 17.2 | 0 | 1 |
| Female pattern hair loss, biological ageing and the Leiden Longevity study | 17.2 | 0 | 1 |
| Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss | 17.2 | 0 | 1 |
| Androgens, hair loss and eugenics: a tale of discovery and American social history | 17.2 | 0 | 1 |
| Patient satisfaction following the use of a hair fiber filler product to temporarily increase the thickness and fullness of thinning hair | 17.2 | 0 | 1 |
| Pigmented concealing powders for the hair loss patient | 17.2 | 0 | 1 |
| Novel amino acid-based surfactant for silicone emulsification and its application in hair care products: a promising alternative to quaternary ammonium cationic surfactants | 17.2 | 0 | 1 |
| Hair follicle dermal stem cells regenerate the dermal sheath, repopulate the dermal papilla, and modulate hair type | 17.2 | 0 | 1 |
| Improving sensitivity and linear dynamic range of intact protein analysis using a robust and easy to use microfluidic device. | 17.2 | 0 | 1 |
| Would pulsed radiofrequency applied to different anatomical regions have effective results for chronic pain treatment? | 17.2 | 0 | 1 |
| Microneedling for the treatment of hair loss? | 17.2 | 0 | 1 |
| PTCA (1H-pyrrole-2,3,5-tricarboxylic acid) as a marker for oxidative hair treatment | 17.2 | 0 | 1 |
| Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma | 17.2 | 0 | 1 |
| Mayo Clinic office visit. Female-pattern hair loss. An interview with Rochelle Torgerson, M.D., Ph.D | 17.2 | 0 | 1 |
| St. Agnes of Rome: patron saint for women with hair loss? | 17.2 | 0 | 1 |
| Transient neonatal hair loss: a common transient neonatal dermatosis | 17.2 | 0 | 1 |
| Potential of tomotherapy for total scalp treatment | 17.2 | 0 | 1 |
| Toward optimal health: the experts respond to hair loss in women. Interview by Jodi Godfrey Meisler | 17.2 | 0 | 1 |
| The Band-Aid Sign of Trichotillomania: A Helpful Diagnostic Technique in the Setting of Hair Loss | 17.2 | 0 | 1 |
| Acute hepatitis after treatment for hair loss with oral green tea extracts (Camellia Sinensis). | 17.2 | 0 | 1 |
| Adverse Effects with Finasteride 5 mg/day for Patterned Hair Loss in Premenopausal Women | 17.2 | 0 | 1 |
| Development and clinical evaluation of green tea hair tonic for greasy scalp treatment | 17.2 | 0 | 1 |
| Exogen Hairs in Women with and without Hair Loss. | 17.2 | 0 | 1 |
| Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss. | 17.2 | 0 | 1 |
| Hair loss is an important symptom of the menopause | 17.2 | 0 | 1 |
| The VAAST Variant Prioritizer (VVP): ultrafast, easy to use whole genome variant prioritization tool | 17.2 | 0 | 1 |
| Screening of physicochemical treatment processes for reducing toxicity of hair care products wastewaters | 17.2 | 0 | 1 |
| Fractional non-ablative laser-assisted drug delivery leads to improvement in male and female pattern hair loss | 17.2 | 0 | 1 |
| Analysis on pharmacokinetics-pharmacodynamics correlation of effective ingredients of Qing'e wan | 17.2 | 0 | 1 |
| A Novel Multi-Targeting Approach to Treating Hair Loss, Using Standardized Nutraceuticals | 17.2 | 0 | 1 |
| Therapeutic efficacy and safety of a 1927-nm fractionated thulium laser on pattern hair loss: an evaluator-blinded, split-scalp study | 17.2 | 0 | 1 |
| Hair Loss: Common Causes and Treatment | 17.2 | 0 | 1 |
| Alkaline Ceramidase 1 Protects Mice from Premature Hair Loss by Maintaining the Homeostasis of Hair Follicle Stem Cells | 17.2 | 0 | 1 |
| Hair Loss in a Young Child | 17.2 | 0 | 1 |
| Hair loss with chemotherapy: at a loss over its management? | 17.2 | 0 | 1 |
| New-Generation Therapies for the Treatment of Hair Loss in Men | 17.2 | 0 | 1 |
| Interaction of effective ingredients from traditional Chinese medicines with intestinal microbiota | 17.2 | 0 | 1 |
| A Review of the Use of Biotin for Hair Loss | 17.2 | 0 | 1 |
| Screening of effective ingredients of Yinzhihuang injection against cholestasis and their mechanism | 17.2 | 0 | 1 |
| Effects of light quality and germplasm on growth and effective ingredients of Dendrobium officinale germchit | 17.2 | 0 | 1 |
| Topical Treatment of Hair Loss with Formononetin by Modulating Apoptosis | 17.2 | 0 | 1 |
| Three cases of liver toxicity with a dietary supplement intended to stop hair loss | 17.2 | 0 | 1 |
| The effects of hair loss in European men: a survey in four countries | 17.2 | 0 | 1 |
| Differential relationships between chronic hormone profiles in pregnancy and maternal investment in rhesus monkey mothers with hair loss in the neonatal period | 17.2 | 0 | 1 |
| Hair loss in children in South-East Nigeria: common and uncommon cases | 17.2 | 0 | 1 |
| Can a topical scalp treatment reduce hair bulb extraction? | 17.2 | 0 | 1 |
| Hair loss with levetiracetam in five patients with epilepsy | 17.2 | 0 | 1 |
| Winter fawn survival in black-tailed deer populations affected by hair loss syndrome | 17.2 | 0 | 1 |
| The effects of tea polyphenolic compounds on hair loss among rodents. | 17.2 | 0 | 1 |
| Sensitive scalp: does this condition exist? An epidemiological study | 17.2 | 0 | 1 |
| Ex-vivo measurement of scalp follicular infundibulum delivery of zinc pyrithione and climbazole from an anti-dandruff shampoo | 17.2 | 0 | 1 |
| Prevalence of scalp disorders and hair loss in children | 17.2 | 0 | 1 |
| Apoptosis in follicles of individuals with female pattern hair loss is associated with perifollicular microinflammation | 17.2 | 0 | 1 |
| Efficacy and Safety of Minoxidil 2% Solution in Combination With a Botanical Hair Solution in Women With Female Pattern Hair Loss/Androgenic Alopecia | 17.2 | 0 | 1 |
| A simple routine method for SDS-electrophoresis of urinary proteins in kidney transplant patients | 17.2 | 0 | 1 |
| Ovarian Leydig cell hyperplasia as a rare cause of hair loss in a postmenopausal female patient: a case report and diagnostic approach toward postmenopausal hyperandrogenism | 17.2 | 0 | 1 |
| Hair regrowth in male and female pattern hair loss does not involve the conversion of vellus hair to terminal hair | 17.2 | 0 | 1 |
| Non-invasive method distinguishes chronic telogen effluvium from mild female pattern hair loss: clinicopathological correlation | 17.2 | 0 | 1 |
| Baseline sebum IL-1α is higher than expected in afro-textured hair: a risk factor for hair loss? | 17.2 | 0 | 1 |
| Gender differences in scalp hair growth rates are maintained but reduced in pattern hair loss compared to controls | 17.2 | 0 | 1 |
| Helmet mold-based surface brachytherapy for homogeneous scalp treatment: a case report | 17.2 | 0 | 1 |
| Clinical use of conditioned media of adipose tissue-derived stem cells in female pattern hair loss: a retrospective case series study | 17.2 | 0 | 1 |
| Effect of a nutritional supplement on hair loss in women | 17.2 | 0 | 1 |
| Is TrichoScan a new diagnostic method for diffuse hair loss? | 17.2 | 0 | 1 |
| Therapeutic efficacy of autologous platelet-rich plasma and polydeoxyribonucleotide on female pattern hair loss. | 17.2 | 0 | 1 |
| Indinavir use: associated reversible hair loss and mood disturbance | 17.2 | 0 | 1 |
| Chronic telogen effluvium and female pattern hair loss are separate and distinct forms of alopecia: a histomorphometric and immunohistochemical analysis | 17.2 | 0 | 1 |
| Seasonality of hair shedding in healthy women complaining of hair loss | 17.2 | 0 | 1 |
| Investigation of four novel male androgenetic alopecia susceptibility loci: no association with female pattern hair loss | 17.2 | 0 | 1 |
| The oestrogen receptor 2 (ESR2) gene in female-pattern hair loss: replication of association with rs10137185 in German patients | 17.2 | 0 | 1 |
| Evaluation of hair loss in cats occurring after treatment with a topical flea control product | 17.2 | 0 | 1 |
| Illuminating current pitfalls in optimal photobiomodulation device development and assessment for treating hair loss | 17.2 | 0 | 1 |
| Selected variants of the melanocortin 4 receptor gene (MC4R) do not confer susceptibility to female pattern hair loss | 17.2 | 0 | 1 |
| Scalp hair loss after transsphenoidal adenomectomy in patients with acromegaly | 17.2 | 0 | 1 |
| Female pattern hair loss possibly caused by tamoxifen: Androgen receptor expression in the outer root sheath in the affected area | 17.2 | 0 | 1 |
| Selected variants of the steroid-5-alpha-reductase isoforms SRD5A1 and SRD5A2 and the sex steroid hormone receptors ESR1, ESR2 and PGR: no association with female pattern hair loss identified | 17.2 | 0 | 1 |
| Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation | 17.2 | 0 | 1 |
| Investigation of the male pattern baldness major genetic susceptibility loci AR/EDA2R and 20p11 in female pattern hair loss | 17.2 | 0 | 1 |
| Assessment of hair density and caliber in Caucasian and Asian female subjects with female pattern hair loss by using the Folliscope. | 17.2 | 0 | 1 |
| Association analysis of oestrogen receptor beta gene (ESR2) polymorphisms with female pattern hair loss | 17.2 | 0 | 1 |
| Lehman's poultry doctor. A treatise on poultry diseases, written in plain language for the farmer and poultry raiser | 17.2 | 0 | 1 |
| Investigation of variants of the aromatase gene (CYP19A1) in female pattern hair loss | 17.2 | 0 | 1 |
| Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study | 17.2 | 0 | 1 |
| Polymorphic CAG repeat numbers in the androgen receptor gene of female pattern hair loss patients | 17.2 | 0 | 1 |
| Trichoscopy for common hair loss diseases: Algorithmic method for diagnosis | 17.2 | 0 | 1 |
| Distinguishing diffuse alopecia areata (AA) from pattern hair loss (PHL) using CD3+ T cells | 17.2 | 0 | 1 |
| Female pattern hair loss: beyond an androgenic aetiology? | 17.2 | 0 | 1 |
| 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss | 17.2 | 0 | 1 |
| Dry skin lesions with marked hair loss in a case of BL leprosy. A case report | 17.2 | 0 | 1 |
| Systematic approach to hair loss in women | 17.2 | 0 | 1 |
| Rewriting public health information in plain language | 17.2 | 0 | 1 |
| The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents | 17.2 | 0 | 1 |
| Study on the dynamic model of supercritical fluid extraction of effective ingredients from natural plant | 17.2 | 0 | 1 |
| An easy to use method to approximate Poisson confidence limits | 17.2 | 0 | 1 |
| The changing patterns of hair density and thickness in South Korean women with hair loss: clinical office-based phototrichogram analysis | 17.2 | 0 | 1 |
| Cross-sectional study of hair loss patterns in 122 Korean systemic lupus erythematosus patients: a frequent finding of non-scarring patch alopecia | 17.2 | 0 | 1 |
| A new classification of pattern hair loss that is universal for men and women: basic and specific (BASP) classification. | 17.2 | 0 | 1 |
| Treatment of female pattern hair loss with a combination of spironolactone and minoxidil | 17.2 | 0 | 1 |
| Health IT Usability Focus Section: Adapting EHR-Based Medication Instructions to Comply with Plain Language Guidance-A Randomized Experiment | 17.2 | 0 | 1 |
| Follicular miniaturization in female pattern hair loss: clinicopathological correlations | 17.2 | 0 | 1 |
| Prospective screening for multiple tumors of the upper aerodigestive tract: a simple routine procedure | 17.2 | 0 | 1 |
| Female patients complaining about hair loss: documentation of defective scalp hair dynamics with contrast-enhanced phototrichogram | 17.2 | 0 | 1 |
| Response to Letter: "Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss". | 17.2 | 0 | 1 |
| Female pattern hair loss, sebum excretion and the end-organ response to androgens | 17.2 | 0 | 1 |
| Female pattern hair loss and its relationship to permanent/cicatricial alopecia: a new perspective | 17.2 | 0 | 1 |
| Prevalence of male and female pattern hair loss in Maryborough | 17.2 | 0 | 1 |
| No association between serum ferritin levels >10 microg/l and hair loss activity in women | 17.2 | 0 | 1 |
| De-constructing home-based care for mental illness: can one identify the effective ingredients? | 17.2 | 0 | 1 |
| COMMON CAUSES OF HAIR LOSS IN MALE AND FEMALE AND SOME RECOMMENDATIONS AS TO TREATMENT | 17.2 | 0 | 1 |
| Scraggly, a new hair loss mutation on mouse chromosome 19. | 17.2 | 0 | 1 |
| Making information easy to use. | 17.2 | 0 | 1 |
| An occasional patient even forgets to remove the protective cap. "Asthma inhalers must be easy to use" | 17.2 | 0 | 1 |
| Topical substance successfully tested in animal experiments. CHemotherapy without hair loss? (interview by Petra Eiden) | 17.2 | 0 | 1 |
| Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss. | 17.2 | 0 | 1 |
| Diffuse Hair Loss Following Multiple Honeybee Stings | 17.2 | 0 | 1 |
| Anaphylaxis to Hymenoptera stings. Effective results of specific desensitization | 17.2 | 0 | 1 |
| Research advance in metabolism of effective ingredients from traditional Chinese medicines by probiotics | 17.2 | 0 | 1 |
| Resolution of methylphenidate osmotic release oral system-induced hair loss in two siblings after dose escalation | 17.2 | 0 | 1 |
| No evidence for follicular keratinocyte hyperproliferation in acne lesions as compared to autologous healthy hair follicles. | 17.2 | 0 | 1 |
| Hair growth promoting effect of white wax and policosanol from white wax on the mouse model of testosterone-induced hair loss | 17.2 | 0 | 1 |
| Prevalence of male pattern hair loss in 18-49 year old men. | 17.2 | 0 | 1 |
| Progressive Hair Loss | 17.2 | 0 | 1 |
| SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss | 17.2 | 0 | 1 |
| Why care about Linear Hair Growth Rates (LHGR)? A study using in vivo imaging and computer assisted image analysis after manual processing (CAIAMP) in unaffected male controls and men with male pattern hair loss (MPHL) | 17.2 | 0 | 1 |
| Patch of hair loss on the scalp | 17.2 | 0 | 1 |
| Two cases of stroke associated with the use of finasteride,an approved drug for male-pattern hair loss in Japan | 17.2 | 0 | 1 |
| Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis | 17.2 | 0 | 1 |
| Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis. | 17.2 | 0 | 1 |
| Serum bilirubin: a simple routine surrogate marker of the progression of chronic kidney disease. | 17.2 | 0 | 1 |
| Two-point scoring method for the evaluation of pattern hair loss by phototrichogram using a headband and a tapeline | 17.2 | 0 | 1 |
| On the history of African hair care: more treasures await discovery | 17.2 | 0 | 1 |